PropThink: AMED Sell-Off To Continue; No Reason To Own as Estimates are Still Too High

[ACN Newswire] – By David MoskowitzAmedisys, Inc. (NASDAQ:AMED) took a 9% hit Monday, as the company announced a major restructuring of its home health services agreement with Humana (NYSE:HUM). HUM is estimated to be … more

View todays social media effects on AMED

View the latest stocks trending across Twitter. Click to view dashboard